About
MilgoSense is an early-stage venture that seeks to disrupt the future of schizophrenia diagnosis, monitoring, and decision-making using simple, non-invasive, cheap, remote and AI-based diagnostic tool.
Schizophrenia is a severe, chronic, and disabling mental disorder affecting approximately 1.1% of the population worldwide. It represents a significant economic burden for patients, payers, and society. Current annual US healthcare estimated costs exceed $155B. It usually starts in teenagers, where the symptoms are confusing and not easy to differentiate from somewhat more typical states of mind at this age. Early diagnosis and treatment may help get symptoms under control and may reduce the need for costly long-term hospitalizations. Early treatment entry may reduce hospitalizations and increase independent living by 41.5–46% and employment by 42–58%.
The fundamental unmet need the company wish to address is the lack of an objective decision-support tool to help prioritize and bring those teenagers in distress as soon as possible to a trained psychiatrist before it is too late.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is MilgoSense's primary focus?
- MilgoSense is an early-stage venture developing an AI-based diagnostic tool for schizophrenia diagnosis, monitoring, and decision-making.
- When was MilgoSense founded?
- MilgoSense was founded in December 2023.
- Where is MilgoSense headquartered?
- MilgoSense is headquartered in Kiryat Ono, Israel.
- What is MilgoSense's current funding stage?
- MilgoSense is currently in the Pre-Funding stage.
- How many employees does MilgoSense have?
- MilgoSense has 1-10 employees.
- Who is the founder of MilgoSense?
- Dovi Kelman is the founder of MilgoSense.
- What technology does MilgoSense primarily use?
- MilgoSense primarily uses Artificial Intelligence in its diagnostic tool.
- What sector does MilgoSense operate in?
- MilgoSense operates in the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics.